In myocardial membranes from hearts with dilated cardiomyopathy (DCM), there was a 37% increase of the Gi1-protein as measured by 32P-ADP-ribosylation of a -40 kDa pertussis toxin substrate. Immunoblotting techniques also showed increased amounts of Gia in DCM. In hearts with ischemic cardiomyopathy (ICM), Gi. was not altered compared with nonfailing myocardium (NF). Basal and Gpp(NH)p-stimulated adenylate cyclase activity was reduced in DCM but not in ICM. The number of f3-adrenoceptors was similarly reduced both in DCM and ICM compared with NF. Alterations of m-cholinoceptors or A,-adenosine receptors did not occur.
human leukemia (HL 60) cells, and membranes from human brain were studied for comparison. Gi, was quantified by pertussis toxin-catalyzed 32P-ADPribosylation and two-dimensional densitometry of immunoblots. ,B-Adrenoceptors, A1-adenosine receptors, and m-cholinoceptors were characterized by radioligand binding experiments. In order to investigate whether the biochemical data have functional relevance, adenylate cyclase activity and the positive inotropic responses to isoprenaline and milrinone, as well as the negative inotropic effects of the A1receptor agonist (-)-N6-phenylisopropyladenosine (R-PIA) or carbachol, were studied. Methods 
Human Tissue
Myocardial tissue was obtained during cardiac transplantation. Explanted hearts from patients with DCM or ICM were compared. Tissue pieces were suspended in ice-cold cardioplegic solution (for composition see next paragraph) and were delivered from the operation room to the laboratory within 5 minutes. Functional studies were performed for each condition in tissue from at least five different patients. All patients gave written, informed consent before operation. Medical therapy consisted of cardiac glycosides, diuretics, and nitrates. All patients with NYHA IV (ICM and DCM) also received the angiotensin converting enzyme inhibitor enalapril. Patients who received catecholamines or f3-adrenoceptor antagonists were withdrawn from the study. Myocardial tissue from six NF hearts that could not be transplanted were studied for comparison. These patients died from injury to the brain. Four males (aged 24, 27, 32, and 36) and two females (aged 25 and 36) were employed in this study. Patient history and twodimensional echocardiography revealed no evidence of heart disease. Tissue procurement of diseased myocardium was the same as in NF. Cardiac catheterization was not performed in the patients without heart failure. Therefore, hemodynamic measurements cannot be given. These patients had been respirated for 48 hours before tissue procurement. Table 1 gives the biographical data and hemodynamic measurements obtained before explantation of the hearts.
General anesthesia was performed with flunitrazepam, fentanyl, and pancuronium bromide with enflurane. Cardiac surgery was performed on cardiopulmonary bypass. The cardioplegic solution used was a modified Bretschneider solution containing (mmol/l) NaCl 15, KCI 10, MgCl2 4, histidine HCl 180, tryptophan 2, mannitol 30, and potassium dihydrogen oxoglutarate 1. Cortex from human brain was obtained within eight hours after death. Tissue was immediately frozen in liquid nitrogen. Membranes were prepared in the same buffer as myocardial membranes. Tissue came from one male (age, 60 years) and one female (age, 62 years).
Radioligand Binding Studies
Membrane preparation for radioligand binding experiments and G-protein determinations. Myocardial tissue was chilled in 30 ml ice-cold homogenization buffer (10 mmol/l Tris-HCl, 1 mmol/l EDTA, 1 mmol/l dithiothreitol; pH 7.4). Connective tissue was trimmed away, myocardial tissue was minced with scissors, and membranes were prepared with a motordriven glass-Teflon homogenizer for 1 minute. Then the membrane preparation was homogenized by hand for 1 minute with a glass-glass homogenizer. The homogenate was spun at 484g (rotor: Beckman JA 20, Beckman, Munchen, FRG) for 10 minutes. The supernatant was filtered through two layers of cheesecloth, diluted with an equal volume of ice-cold 1 mol/l KCl, and stored on ice for 10 minutes. This suspension was centrifuged at 100,000g for 30 minutes. The pellet was resuspended in 50 vol incubation buffer (50 mmol/l Tris-HCl, 10 mmol/l MgCl2; pH 7.4) and homogenized for 1 minute with a glass-glass homogenizer. This suspension was recentrifuged at 100,000g for 45 minutes. The final pellet was resuspended in incubation buffer (50 vol) and stored at -80°C. Storage did not alter the results.
Radioligand Binding Experiments
The assays were performed in a total volume of 250 ,ul incubation buffer. The incubation was performed at 220 C for 120 minutes. These conditions allowed complete equilibration of the receptors with the radioligand. The reaction was terminated by rapid vacuum filtration through GF/C filters (Whatman, Clifton, N.J.), and the filters were each immediately washed three times with 6 ml ice-cold incubation buffer. All experiments were performed three times. Filters were dried at 900 C and placed in 10 ml scintillation fluid (Quickszint 501, Zinsser analytics, Frankfurt, FRG), and radioactivity was determined in a liquid scintillation counter. Myocardial ,B-adrenoceptors were studied using five different (0.5-8 nmol/l) concentrations of 3H-CGP 12.177 ([-]-4-[3 -t-butylamino-2-hydroxy-propoxy]- [5-7-3H] benzimidazol-2-one) as radiolabeled ligand. Specific activity was 52 Ci/mmol; 3 ,gmol/l (-)-propranolol was used to determine nonspecific binding. Cardiac m-cholinoceptors were determined with quinuclidinylbencilate, (R)-(benzilic-4,4-3H[N]) (0.05-2.5 nmol/l; specific activity, 45 Ci/mmol). Nonspecific binding was determined with atropine-sulphate (1 ,amol/l). 3H-Ouabain binding sites were determined according to Erdmann and Schoner'8 to determine the yield of myocardial membranes. Myocardial A1-receptors were measured using 3H-DPCPX (1,3-dipropyl-8-cyclopentylxanthine, 0.05-12.0 nmol/l) as radiolabeled ligand (specific activity, 110 Ci/mmol). In all experiments, 0.2 ,ug/ml adenosine deaminase was present to break down endogenously formed nucleosides. Membranes were preincubated and stirred with the enzyme for 40 minutes at 40 C. At this concentration, adenosine deaminase was capable of abolishing the direct negative inotropic effect of 1,000 ,umol/l adenosine in isolated atrial preparations. Before filtration, filters were presoaked in incubation buffer containing 0.1% (w/v) CHAPS (3 -[[3 -cholamidopropyl] -dimethylammonio] -1propanesulfonate) to reduce nonspecific binding. Specific binding was d,efined as differential binding in the presence and absence of 1 mmol/l theophylline or 10 ,umol/l R-PIA. Nonspecific binding was similar for both agonist and antagonist. The maximum densities (Bma) and apparent affinities (KD) of binding sites were obtained in individual experiments from Scatchard plots determined by linear regression analysis. To study the coupling of A1receptors and m-cholinoceptors, agonist competition experiments were performed with R-PIA and carbachol, respectively, alone and in the presence of the poorly hydrolyzable GTP-analogue guanylylimidodiphosphate (Gpp[NH]p) and analyzed according to De Lean et al. 19 Protein was determined according to Lowry et al.20 (32P)ADP-Ribosylation of G-Proteins by Pertussis Toxin (32P)ADP-ribosylation of G1, by pertussis toxin was performed for 1 hour at 370 C in a volume of 50 ,ul containing 100 mmol/l Tris/HCl (pH 8.0 at 200 C), 25 mmol/l dithiothreitol, 2 mmol/l ATP, 1 mmol/l GTP, 50 nmol/l (32P)NAD (800 Ci/mmol), and 20 ,ug/ml pertussis toxin that had been activated by incubation with 50 mmol/l dithiothreitol for 1 hour at 20°C prior to the labeling reaction. Samples were subjected to SDS polyacrylamide gel electrophoresis (10% [w/v] acrylamide, 16 cm total gel length) according to Laemmli.21 Where indicated, the total gel length was increased to 32 cm, and the separating gel (8% [w/v] acrylamide) was supplemented with 4 mol/l deionized urea to improve resolution of radiolabeled bands. Gels were stained with Coomassie Blue and dried before autoradiography was performed.
Immunoblotting
Immunoblotting techniques22-25 were modified according to Gierschik et al. 23 The retinal transducin holoprotein (GQ) and fly subunits of transducin were purified from bovine rod outer segments as described elsewhere. 23, 24 Production and characterization of the antiserum against transducin holoprotein (AS/1) was performed according to Gierschik et al. 23 The polyclonal antiserum (DS/4) was raised in rabbits against the C-terminal decapeptide of retinal transducin (KENLKDCGLF) coupled to keyhole limpet hemocyanine as described by Goldsmith et al. 25 Under these conditions, this serum was strongly reactive against at, ail, and ai2 and weakly against ai3 and ao. Proteins were transferred from SDSpolyacrylamide gel (10%, 16 cm length, without urea) to nitrocellulose (125 mA, 12 hours, Bio-Rad transblot apparatus). Under this condition, one immunoreactive Gi<, band was detected. The sheets were immersed in 100 ml 3% gelatin in TBS-buffer (20 mmol/l Tris/HCl (pH 7.5), 500 mmol/l NaCl) and shaken for 1 hour at room temperature. Then they were incubated in the first antibody solution (DS/4) containing 200 ,ul antiserum in 50 ml 3% gelatin in TBS (24 hours, room temperature, shaker) to block nonspecific binding. After two washings for 10 minutes with 100 ml TBS containing 0.05% Tween 20, the paper was incubated with the second antibody solution (200 jul peroxidase-labeled goat antirabbit IgG from Kierkegaard and Perry (Gaithersburg, Md.) in 60 ml 1% gelatin in TBS) for 2 hours. After repeated washings, the sheets were transferred to 100 ml TBS and 60 mg dye (4-chloro-1-naphtol) in 20 ml methanol and 60 ,ul 30% H202. Color development was stopped after 10 minutes by rinsing with water, and nitrocellulose was dried between two sheets of filter paper. The amounts of Gi0 in the 40 kDa bands were determined by two-dimensional densitometry (BioRad Video 300A, BioRad, Richmond, Calif.). The relative levels of Gia were calculated in percentages of the 40 kDa band of three of more samples from five NF control hearts according to a technique described elsewhere.'1 In parallel experiments, sheets were stained after electrophoretic transfer with amidoblack lOB (Merck, Darmstadt, FRG) to verify the same amount of protein content and pattern in the groups studied. Other Methods (32P)NAD was prepared from ac-32P-ATP, and pertussis toxin was purified as previously described. 26 Adenylate Cyclase Activity Particulate-washed membrane fractions (10,000g sediment) were prepared according to Kruse and Scholz28 from homogenates of human left ventricular myocardium obtained during cardiac surgery. Myocardium was trimmed off adipose or connective tissues and minced with scissors. The tissue pieces were suspended in 10 vol of their weight of a hypotonic medium (mmol/l) (ATP 2.5, MgCl2 2.5, KHCO3 1, and Tris-HCl 2) at a final pH of 7.4. Membranes were disrupted with an Ultraturrax (Janke and Kunkel, Staufenbreisgau, FRG) at 350 rpm. The suspension was centrifuged at 10,OOOg for 1 minute. The pellet was resuspended and washed four times in hypotonic medium. Finally, the pellet was suspended in KHCO3
(1 mmol/l). The protein concentration was 2 mg/ml. The assay reaction constituents included 40 mmol/l Tris-HCl (pH 7.4), 5 mmol/l MgCl2, 0.3 mmol/l ATP, 0.01 mmol/l EGTA, 300 ,mol/l isobutylmethylxanthine, 5 mmol/l creatine phosphate, 0.1 mg/ml creatine kinase, 1 mg/ml bovine serum albumin, and 200 ,umol/l KHCO3. The final volume was 100 ,l. The reaction was begun by the addition of 20 jil membrane suspension. cAMP (cAMP) was assayed with a modified protein binding technique according to Gilman29 using the commercially available (3H)cAMP radioassay kit (Amersham Buchler, Braunschweig, FRG). cAMP was assayed in a 60-fold dilution. The reaction was linear within 20 minutes.
Contraction Studies
The experiments were performed on electrically driven (1 Hz) papillary muscle strips. Papillary muscle strips of uniform size (diameter, < 1.0 mm; length, 3-6 mm) were dissected in aerated bathing solution at room temperature. The preparations were attached to a bipolar platinum stimulating electrode and individually suspended in 75 ml glass tissue chambers for recording isometric contractions. The bathing solution was a modified Tyrode solution containing (mmol/l) NaCl 119.8, KCl 5.4, CaCl2 1.8, MgCl2 1.05, NaH2PO4 0.42, NaHCO3 22.6, Na2 EDTA 0.05, ascorbic acid 0.28, and glucose 5.0. It was continuously gassed with 95% 02 and maintained at 350 C; the pH was 7.4. The force of contraction was measured with an inductive force transducer (W. Fleck, Mainz, FRG) attached to a Hellige Helco Scriptor (Hellige, Freiberg, FRG) or Gould recorder (Cleveland, Ohio). Each muscle was stretched to the length at which force of contraction was maximal. The resting force (approximately 5 mN) was kept constant throughout the experiment. The preparations were electrically paced at 1 Hz with rectangular pulses of 5 msec duration (Grass stimulator SD 9, Quincy, Mass.), and the voltage was about 20% greater than threshold. All preparations were allowed to equilibrate in a drug-free bathing solution until complete mechanical stabilization was reached.
Positive inotropic responses to isoprenaline and milrinone were determined with cumulative concen- 
Materials
Forskolin, carbachol, 4-chloro-1-naphtol, and by cutting out the bands and measuring incorporated radioactivity with a scintillation counter. Membranes were derived from failing myocardium due to dilated cardiomyopathy. 150 chloronaphtol were purchased from Sigma. All other compounds used were of analytical or best grade commercially available. Only deionized and twice-distilled water was used throughout.
Statistical Evaluation
The data shown are mean+SEM. Statistical significance was estimated with Student's t test for unpaired observations and analysis of variance. A p value of less than 0.05 was considered significant. KD values and the drug concentration producing 50% of the maximum effect (EC50) were graphically determined in each individual experiment. The KD and EC50 values are given with 95% confidence limits. Highand low-affinity binding of the agonist and the influence of Gpp(NH)p on agonist competition curves were analyzed by the computer modeling method of De Lean et al. 19 One-and two-site fits were tested for improvement of the fit by an F test. The one-or two-site model was judged to be appropriate when it was significantly better (p<0.0001) than the preceding one. The data of the functional studies were evaluated according to Wallenstein et al.30
Results
Pertussis Toxin Substrates Figure 1 shows the incorporation of 32P-ADPribose into a =40 kDa membrane protein as a function of the amount of protein. The protein was increased from 10 ,ug/lane to 150 ,ug/lane. The inset illustrates that 32p incorporation into the protein was enhanced by increasing the protein content. The curve indicates that incorporation of radioactivity was linear within the range studied. The membranes used were from the hearts of patients with DCM. Figure 2 shows the incorporated radioactivity into myocardial membranes of hearts from patients with DCM or ICM and from NF controls. The total amount of incorporated radioactivity was increased 37% in myocardial membranes from hearts with FIGURE 2. Incorporation of 32P-ADP-ribose into a -40-kDa pertussis toxin substrate membrane protein in nonfailing myocardium (control, nine samples from three hearts), ischemic cardiomyopathy (ischemic heat disease, nine samples firom five hearts), and dilated cardiomyopathy (15 samples from five hearts). All samples were taken from different parts of the left ventricle and separated on 10% SDS-polyacrylamide gel electrophoresis in parallel on the same day. Samples from nonfailing hearts were studied on each gel as controls. Values represent the mean ±SEM. DCM compared with those from NF. Conversely, there was no difference between NF and ICM in the amount of radioactivity incorporated into the =40 kDa protein.
To investigate whether the increased labeling of the -40 kDa membrane protein is due to increased levels of Gia proteins in the membrane or to changes of other factors necessary for the ADP-ribosylation reaction, we examined the levels of Gla by immunoblotting. An antibody directed against the C-terminal decapeptide of transducin was used. Figure 3 in each group; NS). Since the antibody was raised against a synthetic peptide identical to the C-terminal decapeptide of transducin, it is unlikely to be specific for the C%2 subunits because of homologies to transducin, ail, and ci2.
32P-ADP-ribosylation is not only dependent on the a-subunits but also on the amount of f,y-subunits. 30,3' To study whether alterations of these components occur, fly-subunits were studied with a polyclonal antiserum reactive against the =36 kDa f-subunits of transducin. A typical experiment is shown in Figure  4 . It is evident that there was no significant difference in the fly-subunits among ICM, DCM, or NF. This finding indicates that alterations of the a-subunits but not the fly-subunits occur in DCM. It is known that the myocardium contains more than one substrate for pertussis toxin-catalyzed ADP-ribosylation. To elucidate how many and which types of pertussis toxin substrates occur in the human myocardium, membranes were separated on SDS-urea gels, which provide a better resolution of the individual G-protein a-subunits. A typical experiment is shown in Figure 5 . Four membrane proteins at Mr=39, =40, =41, and =42 kDa were identified in all groups as pertussis toxin substrates.
The four pertussis toxin substrates apparently present in the human heart were further characterized by comparing pertussis toxin substrates of myocardial 40 kDa membranes with those in other human tissues (i.e., human brain and human leukemia [HL 60] cells) ( Figure 6 ). The Goa in myocardial membranes of the hearts studied (not shown). The :41 kDa protein was present in myocardial, brain, and HL 60 membranes. 32P-ADPribosylation of a ;42 kDa pertussis toxin substrate was present in myocardium and brain but not in HL 60 cells. Taken together, four pertussis toxin substrates ('z39, -40, :41, and :42 kDa) could be detected in human heart muscle, the z40 kDa pertussis toxin substrate being the major G-protein in the human heart. In failing hearts with DCM, the degree of pertussis toxin-catalyzed 32P-ADPribosylation is increased, and the 40 kDa substrate exhibits the most pronounced change. Adenylate Cyclase Activity To study whether the differential increase of Gia in DCM and ICM has an impact on the regulation of adenylate cyclase, adenylate cyclase activity was studied in these membranes under various conditions. The data are summarized in Figure 7 . There was no significant difference in basal enzyme activity between NF and ICM. Conversely, in DCM there was a decrease of 54% in basal enzyme activity compared with NF. In ICM and NF there was no significant difference. Similar and even more pronounced differences were observed when the effect of the hydrolysis-resistant GTP-analogue Gpp(NH)p (100 gmol/l) was studied. This derivative increased adenylate cyclase activity in membranes of NF about 10-fold. In isoprenaline and forskolin were studied without GTP, which was not required for forskolin stimulation of adenylate cyclase and was apparently present at a sufficiently high concentration in the adenylate cyclase assay to allow receptor activation of Gs. Cardiac f3-Adrenoceptors, A,-Adenosine Receptors, and m-Cholinoceptors Cardiac ,B-adrenoceptors were measured using 3H-CGP 12.177 as radioligand. These experiments were performed to compare the biochemical impairment of severe heart failure in both groups. The data for all hearts studied are summarized in Table 2 . There was a marked decline in the number of f3-adrenoceptors in ICM and DCM compared with NF. Reduction of receptor number was independent of the underlying cause of cardiomyopathy. The same results were obtained when the data were related to the amount of membrane protein or bound pmol 3H-ouabain to exclude an influence of a different yield of myocardial membranes in the groups ( Table 2 ). The numbers of 3H-ouabain binding sites were (pmol/mg protein) 5.4+0.7 (n-5) in NF, 4.9+0.5 (n=6) in DCM, and 5.2±0.4 in ICM. Adenylate cyclasecoupled inhibitory receptors were studied in the same hearts using 3H-DPCPX and 3H-QNB for Aladenosine receptors and m-cholinoceptors, respectively. Table 2 summarizes the data. In contrast to ,8-adrenoceptors, the number of binding sites did not differ in DCM, ICM, and NF. As with ,3-adrenoceptors, B,,,,, values were not different when related to milligrams of membrane protein or bound pmol 3H-ouabain ( Table 2 ). The antagonist affinities of ,B-adrenoceptors, m-cholinoceptors, and A1-adenosine receptors did not differ among the groups. Figure 8 shows typical saturation experiments for all ligands in one heart. Binding was saturable and revealed one class of binding sites in all instances. The composite number of f3-adrenoceptors in DCM and ICM was similarly reduced, whereas the number of m-cholinoceptors and A1-adenosine receptors was unchanged.
ICM DCM Std
Since the level of Gi,0 was increased in DCM it is conceivable that Gi-Aladenosine receptor or Gi,,m-cholinoceptor coupling might be facilitated. One approach to the study of receptor-G-protein coupling is to compare high-affinity agonist receptor binding with its reversal by guanine nucleotides such as Gpp(NH)p. Figure 9A illustrates a representative competition experiment with carbachol for 3H-QNB binding. Three affinity states (i.e., super-high, high, and low) could be detected. In the presence of 100 1umol/l Gpp(NH)p, only the highand low-affinity components of carbachol competition were detectable. Table 3 summarizes the data obtained in all hearts studied. The parameters of super-high, high-, and low-affinity states did not differ in DCM or ICM when compared with NF. The influence of Gpp-(NH)p on agonist binding did not differ among groups. Figure 9B shows a competition experiment with R-PIA-to-3H-DPCPX binding. With R-PIA alone, one highand one low-affinity component of agonist competition were detected. In the presence of Gpp(NH)p, the competition curve revealed only one class of low-affinity binding sites. Table 3 shows that neither densities nor affinities of highand low-affinity binding sites differed significantly among the groups.
Concomitantly, alterations of m-cholinoceptor or A,adenosine receptor coupling measured by agonist competition experiments were not observed.
Effects of Carbachol and R-PI4 on Contractile Force
In order to evaluate whether the negative inotropic effects of carbachol ( Figure lOA ) and R-PIA (Figure lOB) are altered in ICM or DCM, the effects of the compounds were studied in the presence of forskolin. We used forskolin since the positive inotropic effects of isoproterenol and milrinone are differentially reduced (see next paragraph) in cardiomyopathic tissue. Forskolin (0.3 Lmol/l) similarly increased contractile force to 329±50% (n = 16) and 296+28% (n =24) of predrug value in DCM and ICM, respectively (NS). From Figure 10 and Table 4 it is evident that the efficacies and potencies of carbachol and R-PIA in reducing contractile force in the presence of forskolin were similar in ICM and in DCM. Experiments were performed with and without 0.2 ,g/ml adenosine deaminase. This concentration was capable of abolishing the direct negative inotropic effect of 1,000 ,umol/l exogenous adenosine in atrial myocardium (not shown). The antiadrenergic effect of R-PIA did not differ when applied alone or in the presence of adenosine deaminase (data not shown). Thus, endogenous adenosine does not alter the response to R-PIA. Compositely, the antiadrenergic effects of carbachol and R-PIA did not differ in ICM and DCM. The effects of these compounds in preparations from two NF hearts also were not different.
Positive Inotropic Effects of Isoprenaline and Milrinone
To examine whether the biochemical alterations have functional consequences for contractile force of the failing myocardium, the positive inotropic effects of milrinone and isoprenaline were studied. Figure  11 shows concentration-response curves for the effects of isoprenaline on isometric force of concentration in papillary muscle strips from patients with DCM and ICM. The results in preparations from five NF hearts are given for comparison. In both DCM and ICM, there was a reduction of the maximum positive inotropic effects of isoprenaline compared with NF. A more pronounced decline of the maximum positive inotropic effect of isoprenaline was observed in DCM than in ICM. The positive inotropic effect of the phosphodiesterase inhibitor milrinone acting "distal" to ,B-adrenoceptor stimulation was also studied (Figure 12 ). In both groups, the effect of milrinone was markedly reduced compared with NF. As with isoprenaline, the reduction of the maximum positive inotropic effect of milrinone was more pronounced in DCM than in ICM hearts. EC50 values and absolute values for the positive inotropic effects are given in Table 4 . Because of similar numbers of ,B-adrenoceptors, this difference indicates that an additional mechanism other than receptor downregulation might be functionally relevant for the myocardium with DCM.
Discussion
The results of the present study are that GiC, ICM and DCM. Basal and Gpp(NH)p-stimulated adenylate cyclase activities were reduced in dilated but not in ischemic myocardium, whereas the effectiveness of forskolin in this respect was similar in all groups. Radioligand binding studies indicated that alterations of inhibitory m-cholinoceptor or A1adenosine receptor coupling were not involved. The antiadrenergic effect of carbachol or R-PIA also were consistently not different in ICM and DCM. Moreover, the antiadrenergic effect was similar in preparations from NF hearts. The increase in Q,, and reduction of adenylate cyclase activity may be of functional importance since the positive inotropic effects of isoprenaline and milrinone as well were reduced in myocardium from patients with DCM as compared with those with ICM. myocardial failure, a decline in the number of lrenoceptors was previously observed.5,10 This ing is allegedly due to a loss of cardiac 831-adrenoors by the permanent stimulus imposed on the t by elevated plasma noradrenaline levels in these :nts.2,4,33 However, evidence has accumulated that r alterations within the adenylate cyclase complex contributing to the blunted positive inotropic rese to /3-adrenoceptor agonists,5-8 as well as to ,phodiesterase inhibitors9,10 and histamine. 8 The tive inotropic effects of Ca21 is reportedly unged. 8, 9 In the present investigation, a reduction of iac ,B-adrenoceptors was observed in failing myoium due to DCM or ICM, which was comparable revious studies.5-8 This reduction of 13-adrenocepis closely related to the severity of the disease.8 Concentration of carbachol (pmol/1) FIGURE 9 . Competition ofcarbachol (0. 01-2,000 ,umolIl) to 3H-QNB binding (0.5 nmoll 1, A) and R-PIA (0.1-10,000 nmolIl) to 3H-DPCPX binding (3.0 nmolIl, B) to myocardial membranes from a 54-year-old male patient who was transplanted for terminal heart failure due to dilated cardiomyopathy. Experiments were performed with and without 100 pmol/l Gpp(NH)p. Each point represents the mean of triplicate observations. 0.1 1 10 100 1000 10 000
Concentration of R-PIA (nmol/l) These results provide evidence that the patients in both groups were in the same stage of heart failure.
The increased amount of Gia, shown here in DCM but not in ICM might produce augmented tonic inhibition of adenylate cyclase. This might in turn lead to a blunted response to cAMP-increasing positive inotropic agents. Recently, Feldman et all' reported a 36% increase of a =40 kDa pertussis toxin substrate in the failing heart. This phenomenon was accompanied by reduced basal adenylate cyclase activity in the diseased hearts. In the latter study, only hearts with failure due to DCM were investigated. Hence, the data of this study and those of our investigation are congruent. However, when patients with heart failure of the same functional class (NYHA IV) and a similar biochemical impairment -as judged from the reduction of cardiac ,B-adrenoceptorsdue to ICM were studied, the increase of :40 kDa Gi, protein was not observed. A recent investigation reported unchanged or even decreased 32P-ADP ribosylation of a :40 kDa protein in one heart with myocarditis and two hearts with ICM.34 Our findings and the results of the latter study reveal that alterations of Gia proteins do not necessarily parallel the severity of heart failure but might be related to the underlying pathogenesis of myocardial disease. G-proteins play a pivotal role in the regulation of a number of physiological processes, such as inhibition or stimulation of adenylate cyclase activity or gating of ionic channels (for review, . In the failing myocardium of dogs, reduced amounts of Gsa were detected by cholera toxin-induced ADPribosylation.39 However, in human myocardium, ADP-ribosylation of a -45 kDa G,i-like protein was similar in cardiac membranes from failing and NF hearts.'1 In the canine heart, it has been reported that two pertussis toxin substrates are expressed.22 Therefore, the increase of ':40 kDa 32P-pertussis substrate was further investigated by use of SDS-gels with 4 mol/1 urea, which increased the resolution of membrane proteins. These experiments clearly demonstrated that four pertussis toxin substrates can be Displacement of 3H-DPCPX (A1-adenosine receptors) and 3H-QNB (m-cholinoceptors) binding with the agonists R-PIA and carbachol, respectively, alone and in the presence of Gp p(NH)p in myocardial membranes from the left ventricles of patients with dilated cardiomyopathy (DCM), ischemic cardiomyopathy (ICM), and nonfailing myocardium (NF). Mean estimates of the super high (KsH), high (KH) and low (KL) dissociation constants (in nmol/l) or the percentage of receptors in the super high (RsH), high (RH) or low (RL) affinity states are given.
identified in the human heart. Comparison of NF and myocardium from patients with DCM showed that labeling of all pertussis toxin substrates is increased in the latter group. Since Gia2 is the =40 kDa pertussis toxin substrate in HL 60 cells,40 it is not unreasonable to assume that Gia2 may be increased in DCM as measured by this method. However, because of great homologies between the a, subtypes, antibodies that are simultaneously highly specific and sensitive enough to detect a, proteins in myocardial membranes are not available, and hence a final subclassification cannot be made at this time. It was recently shown by kinetic studies of pertussis toxininduced ADP-ribosylation that Gia is most likely to be involved in the inhibition of cardiac adenylate cyclase. 41 Therefore, the increase of these G-proteins might be involved in the reduced cAMP-formation in human DCM.
Pertussis toxin labeling could be influenced by fly subunits.3132 Immunoblots of fl-subunits (Mrz36 kDA), which are allegedly identical in all types of G-proteins,36 indicated no difference among the three groups. This finding demonstrates that alterations on the level of the By-subunit are not involved. To test whether the accessibility for pertussis toxin or the amount of Gja is responsible, immunoblotting techniques were performed with antibodies raised against the C-terminal decapeptide of transducin. 30, 31 These experiments showed that the =40 kDa pertussis toxin substrates of the heart, presumably identical with the =40 kDa proteins of HL 60 cells, were also found to be increased in dilated cardiomyopathy by this technique. One may hypothesize that an increase of Gia in the presence of unchanged amounts of fly-subunits might enhance the activity of Gsa by reducing the availability of fly-subunits to form a trimeric complex with GSa.
However, there are three arguments against the concept that 8y-subunits inhibit adenylate cyclase merely by acting as a sink for c}. Gia is capable of inhibiting adenylate cyclase in membranes of the a,-deficient S49 mouse cyc-lymphoma mutant. 42 In these cells, adenylate cyclase inhibition is under hormonal control. 43 Moreover, cholera toxin reduces the affinity of a; for ,fy-subunits, while hormonal adenylate cyclase inhibition is unchanged.44"45 Finally, any G-protein-mediated stimulus of effectors other than adenylate cyclase, such as the chemoattractant FMLP receptor on neutrophils,46 would release fly-subunits and would inhibit adenylate cyclase, which is not the case. 46, 47 In this study, decreased basal and Gpp(NH)pstimulated adenylate cyclase activity was found in DCM but not in ICM. In failing myocardium with reduced fi-adrenoceptors, the isoprenaline-stimulated adenylate cyclase activity was reportedly reduced,5-7 but basal adenylate cyclase was unchanged.5 These earlier studies were performed without separating the tissues in terms of the underlying cause of heart failure.5 In a more recent study by ing reduced isoprenaline-stimulated adenylate cyclase activity in cardiomyopathic tissue. The catalyst of adenylate cyclase seems unchanged, as forskolin-stimulated adenylate cyclase is unaffected. However, since basal and Gpp(NH)p-stimulated adenylate cyclase activity was more sharply reduced in DCM, it may be concluded that this loss of activity is caused by increased levels of Gia. This discovery is supported by findings in isolated myocardial cells, in which treatment with pertussis toxin resulted in an augmented cAMP-formation after f3-adrenoceptor stimulation. 16 The present data indicate that an increase of Gia has an impact on adenylate cyclase activity in DCM. Adenosine produces negative inotropic effects on contractile force in the presence of cAMP-increasing agents such as isoprenaline,12-15 phosphodiesterase inhibitors,48 or forskolin.49 It is released from the heart during excessive stimulation by catecholamines,12 ischemia,50 increased cardiac work load,51,52 or heart failure,53 and it is believed to protect the myocardium as an endogenous feedback inhibitor from excessive ,8-adrenergic stimulation.12 A defective adenosinemediated feedback control due to impaired anti-adrenergic effects has been hypothesized to play a causative role in human hypertrophic cardiomyopathy.56 However, data on the role of A1-adenosine receptors in human cardiomyopathy are lacking. The negative inotropic effects of adenosine are shared by m-cholinoceptor agonists. A1-adenosine receptormediated and m-cholinoceptor-mediated effects involve a pertussis toxin-sensitive G-protein.1617,54,55 These findings provide evidence that an increase of Gi,a might produce facilitated coupling and pronounced antiadrenergic effects of these receptors in DCM. The density of highand low-affinity states of agonist binding and antagonist affinity of adenosine receptors were not altered in DCM, ICM, and NF, as was the case with m-cholinoceptors. In ICM, DCM, and NF, three affinity states of the receptors were identified. These results are similar to those observed in dog myocardium.57 However, there was no difference in the distribution of the various affinity states of the m-cholinoceptors among the three groups. Moreover, there was no difference in the antiadrenergic effect of R-PIA and carbachol between ICM and DCM. Therefore, even with an increase of Q, stim- The maximal effects are given in percent of predrug value or change in force of contraction in mN; n gives the number of hearts; p gives the number of preparations. EC50, ICQ values and maximal responses for the effects on force of contaction of isoprenaline (Iso), milrinone (Mil), and R-N6-phenyl-isopropyladenosine (R-PIA) or carbachol (Carb) in the presence of forskolin (0.3 gmol/l) in isolated electrically driven (1 Hz) papillary muscle strips from hearts with dilated (DCM) or ischemic (ICM) cardiomyopathy and nonfailing myocardium (NF hypothesis is substantiated by the higher levels of Gia proteins (about 0.1% membrane protein) than Aladenosine or m-cholinoceptors that are only in the fmol range (about 0.00001% of total membrane protein, this study). The data also provide evidence that different subclasses of Gia could exist within the membrane compartment, one of them coupling Aladenosine receptors or m-cholinoceptors to the adenylate cyclase and the other producing adenylate cyclase inhibition. These data contrast with findings in canines with heart failure due to chronic pressure overload, in which a reduction of m-cholinoceptors and a loss of high-and super-high-affinity binding sites has been reported.58 Moreover, these findings demonstrate that one cannot extrapolate from alterations in the model of pressure overload in dogs to human heart failure because entirely different alterations such as a decrease of GQ,38 unchanged GQ,"38,58 and a reduction of m-cholinoceptors57 are found.
The question arises whether these biochemical alterations have an impact on the capability of cAMP-increasing positive inotropic agents to increase contractile force. It is well established that P-adrenoceptor agonists,5-'0 phosphodiesterase inhibitors,8-10 and histamine8 have reduced positive inotropic effects in isolated myocardial tissue from failing hearts in vitro. Moreover, intracoronary infusions of dobutamine and milrinone increased contractile force less markedly in patients with heart failure than in control subjects,59 indicating that the reduced positive inotropic effects of cAMPincreasing positive inotropic agents are also detectable under clinical conditions. The effect of forskolin is reportedly unchanged in failing myocardium. 8, 9, 60 It more sharply increases adenylate cyclase activity than do ,B-adrenoceptor agonists.60 Hence, Gia-mediated cyclase inhibition may not be sufficient to reduce the positive inotropic effect of forskolin when cAMP levels are increased to concentrations at which contractile force is already maximally stimulated. In this study, the effects of isoprenaline and milrinone were reduced in both DCM and ICM. The positive inotropic effect of the phosphodiesterase inhibitor milrinone was markedly reduced in ICM compared with NF. Since the amount of Gia was similar in NF and ICM, these findings indicate that the reduction of positive inotropic effects is probably not related only to an increase of Gia. Recently, a close correlation of the reduced maximum positive inotropic effect of milrinone to the number of cardiac 13-adrenoceptors was reported.10 Hence, one hypothesis is that a reduction of the number of 13-adrenoceptors not occupied by an agonist could play a role in reducing positive inotropic responses to cAMP-increasing agents such as phosphodiesterase inhibitors in intact preparations. 3-Adrenoceptors without agonists reconstituted in phospholipid vesicles are capable of stimulating GTPase activity and, hence, the respective effector system.61 These suggestions provide possible explanations of why the effects of phosphodi-esterase inhibitors are reduced depending on the degree of fB-adrenoceptor downregulation. Since Ga also affects coupling of agonist-occupied /3-adrenoceptors in the presence of G, to the catalytic subunit of the adenylate cyclase,62 this activity might contribute to the reduced positive inotropic response to at least isoprenaline in DCM. Therefore, Gia might play multiple roles in reducing cAMP-dependent positive inotropic effects in the myocardium.
This experimental study is limited in the general difficulty of exactly quantifying the amounts of Gia proteins in myocardial membranes and their changes in different types of cardiomyopathies. ADPribosylation by pertussis toxin could be potentially influenced by the availability of Gia for pertussis toxin or endogenous ADP-ribosylation. The applied immunoblotting methods and their quantification by twodimensional densitometry or labeling with iodinated protein A is only semiquantitative. Therefore, future work must focus on new techniques to determine exact membrane densities of G-proteins in membrane preparations.
To summarize, the further reduction of positive inotropic effects despite a similar downregulation of ,3-adrenoceptors in DCM provides strong evidence that the increased levels of Gja and reduced basal adenylate cyclase activity are of functional importance for the regulation of contractility. This alteration appears to be dependent on the underlying cause of heart failure. The clinical relevance of these experimental data is exemplified by the paucity of long-term effects of ,B-adrenergic drugs and phosphodiesterase inhibitors. Additionally, inactivation of Gia could be a potential target for the medical treatment of chronic heart failure due to DCM.
